Counterpoint Mutual Funds’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,759
Closed -$297K 327
2025
Q4
$297K Sell
3,759
-225
-6% -$17.6K 0.02% 254
2025
Q3
$318K Buy
+3,984
New +$340K 0.03% 292

Other funds holding CL

Counterpoint Mutual Funds's CL Position: Q1 2026 in Review

Counterpoint Mutual Funds sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 3,759 shares — an estimated $297K sold.

Counterpoint Mutual Funds first reported a position in CL in Q3 2025 and held it in 2 quarters. The position peaked at $318K in Q3 2025. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Counterpoint Mutual Funds reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 3,759 Colgate-Palmolive shares in Q1 2026, an estimated $297K.
  • Counterpoint Mutual Funds first reported a position in Colgate-Palmolive in Q3 2025 and held it in 2 quarters.
  • Counterpoint Mutual Funds's Colgate-Palmolive position peaked at $318K in Q3 2025.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2026, filed 27 Apr 2026.